Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Stefania Liva

Showing results (1-10 of 3) with videos related to

Pageof 1
Sort By:
European Journal of Gastroenterology & Hepatology|April 16, 2002
The UDCA dosage deficit: a fate shared with CDCAEnrico Roda, Stefania Liva, Francesco Ferrara, et al.
World Journal of Gastroenterology|July 11, 2003
Gastric autoimmune disorders in patients with chronic hepatitis C before, during and after interferon-alpha therapyCarlo Fabbri, M Francesca Jaboli, Silvia Giovanelli, et al.
World Journal of Gastroenterology|July 11, 2003
Long-term alpha interferon and lamivudine combination therapy in non-responder patients with anti-HBe-positive chronic hepatitis B: results of an open, controlled trialM Francesca Jaboli, Carlo Fabbri, Stefania Liva, et al.
Pageof 1

Showing results (1-10 of 3) with videos related to

Sort By:
Pageof 1
European Journal of Gastroenterology & Hepatology|April 16, 2002
The UDCA dosage deficit: a fate shared with CDCAEnrico Roda, Stefania Liva, Francesco Ferrara, et al.
World Journal of Gastroenterology|July 11, 2003
Gastric autoimmune disorders in patients with chronic hepatitis C before, during and after interferon-alpha therapyCarlo Fabbri, M Francesca Jaboli, Silvia Giovanelli, et al.
World Journal of Gastroenterology|July 11, 2003
Long-term alpha interferon and lamivudine combination therapy in non-responder patients with anti-HBe-positive chronic hepatitis B: results of an open, controlled trialM Francesca Jaboli, Carlo Fabbri, Stefania Liva, et al.
Pageof 1